-
Scribe Therapeutics Announces Pricing of Upsized Initial Public Offering
July 23, 2026 21:08 ET | Source: Scribe Therapeutics Inc. ALAMEDA, Calif., July 23, 2026 (GLOBE NEWSWIRE) — Scribe Therapeutics Inc. (“Scribe Therapeutics”) (Nasdaq: SCTX), a clinical-stage biotechnology company engineering purpose-built in vivo CRISPR technologies designed to extend healthy lifespan through disease prevention and durable therapeutic intervention, today announced the pricing of its upsized initial…
-
Cosmos Health Share Buyback Surpasses $1 Million, Reaching 4.84 Million Shares; Continues Open Market Repurchases
CHICAGO, July 16, 2026 (GLOBE NEWSWIRE) — Cosmos Health Inc. (“Cosmos Health” or the “Company”) (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced that it has repurchased an additional 250,000 shares of its common stock in the open market at an average price of approximately $0.2782 per share. The Company has now repurchased a…
-
Teladoc Health Announces Employee Inducement Award under NYSE Rule 303A.08
July 03, 2026 16:30 ET | Source: Teladoc Health, Inc. NEW YORK, July 03, 2026 (GLOBE NEWSWIRE) — Teladoc Health, Inc. (NYSE: TDOC), the global leader in virtual care, today announced that it issued an inducement award to a new employee. Effective July 1, 2026, in connection with commencing employment as Head of Product of…
-
Bond Announces Conversion of Outstanding Debt into Equity at Significant Premium to Market
June 16, 2026 08:07 ET | Source: Our Bond, Inc. Major Investor Exchanges Approximately $3.3 Million of Debt for Convertible Preferred Equity Priced at $2.0265 Per Common Share — a Premium of More Than 200% to Recent Trading Levels Above-Market Conversion Along With Separate Payment Schedule Adjustment Reduce 2026 Debt Burden By $4.3M, Reflecting Investors’…
-
SMT Celebrates 20 Years of the Cocoon Occluder Journey, Transforming Lives in Congenital and Structural Heart Defects
Mumbai, Maharashtra, India Congenital Heart Disease (CHD) is one of the most common birth defects, affecting approximately 1% of live births globally and accounting for more than 4.18 million cases in children under five1. Despite advances in medical care, CHD continues to be a leading cause of infant and child mortality, highlighting the need for…
-
Quantinuum Announces Closing of Upsized Initial Public Offering
BROOMFIELD, Colo., June 5, 2026 /PRNewswire/ — Quantinuum Inc. (Nasdaq: QNT) (“Quantinuum”) today announced the closing of its upsized initial public offering of 28,000,000 shares of its Class A common stock at an initial public offering price of $60.00 per share. All of the shares were offered by Quantinuum. The aggregate gross proceeds from the…
-
Scottish football unites to tackle most common cancer in young men
Scottish football is uniting this weekend to tackle the most common cancer affecting young men, as clubs across the country back a national awareness campaign encouraging men to check themselves and catch the disease early. “Tackling Testicular Cancer”, led by Cahonas Scotland in partnership with PFA Scotland, is using the reach of the game to…
Latest News
About the Author
We increase the awareness of millions of users through our news networks. We are one of the most trusted news networks in the world.